Loved and loathed: The making of India’s viral liver doctor
The waiting room outside the hepatology clinic at Rajagiri Hospital in Kochi is suspended between hope and despair.…
States seek to lower drug prices by targeting the companies that manage them for health plans
TOPEKA, Kan. — As consumers worry about medication costs, states are trying to lower drug prices by reining…
Nearly 1 million bottles of heart and kidney medication recalled: FDA
Kardigan co-founder and CEO Tassos Gianakakos discusses the new leads his company has found in battling heart disease…
Patients can save thousands with drug coupons, but only if insurers honor them
For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Florida, received a coupon card to help…
The five common medicines that could be harming your hearing
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Illegal peptides: Surge in demand for sterile equipment puts pressure on Victoria’s needle and syringe programs
Save You have reached your maximum number of saved items. Remove items from your saved list to add…
FDA Raids Private Hospital, Seizes Illegally Stored Medicines | Nagpur News
Nagpur: The Food and Drug Administration (FDA) on Saturday raided a private hospital in Quetta Colony and seized…
11 topical minoxidil alternatives to boost hair growth
For years, topical minoxidil has been the gold-standard treatment for hair growth. So, it’s no surprise that its…
Quackery in Quebec: The Trojan Horse Bill I Worry About | Office for Science and Society
A new bill has been proposed at the National Assembly of Quebec, and while it may look like…
Hypnotherapy cures food phobic who only ate potatoes for 40 years
A mom who could only eat potatoes, chips and mash for 40 years has been cured thanks to…
Internal documents show B.C. approved free nasal naloxone expansion after criticism over delays
As the province continues to roll out broader access to free nasal naloxone this week, documents obtained by…
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…